Development of experimental fibrotic liver diseases animal model by Carbon Tetracholoride.

MLA

Gitiara, Atoosa, et al. “Development of Experimental Fibrotic Liver Diseases Animal Model by Carbon Tetracholoride.” Gastroenterology & Hepatology from Bed to Bench, vol. 10, Oct. 2017, pp. S122–28. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=127555622&authtype=sso&custid=ns315887.

APA

Gitiara, A., Tokhanbigli, S., Mazhari, S., Baghaei, K., Hatami, B., Hashemi, S. M., Rad, A. A., Moradi, A., Nasiri, M., Ahrabi, N. Z., & Zali, M. R. (2017). Development of experimental fibrotic liver diseases animal model by Carbon Tetracholoride. Gastroenterology & Hepatology from Bed to Bench, 10, S122–S128.

Chicago

Gitiara, Atoosa, Samaneh Tokhanbigli, Sogol Mazhari, Kaveh Baghaei, Behzad Hatami, Seyed Mahmoud Hashemi, Ali Asadi Rad, et al. 2017. “Development of Experimental Fibrotic Liver Diseases Animal Model by Carbon Tetracholoride.” Gastroenterology & Hepatology from Bed to Bench 10 (October): S122–28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=127555622&authtype=sso&custid=ns315887.